- Home
- IKT vs PEBK Comparison
IKT vs PEBK Comparison
Compare IKT & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- PEBK
- Stock Information
- Founded
- IKT 2008
- PEBK 1912
- Country
- IKT United States
- PEBK United States
- Employees
- IKT N/A
- PEBK N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- PEBK Major Banks
- Sector
- IKT Health Care
- PEBK Finance
- Exchange
- IKT Nasdaq
- PEBK Nasdaq
- Market Cap
- IKT 167.2M
- PEBK 169.6M
- IPO Year
- IKT 2020
- PEBK N/A
- Fundamental
- Price
- IKT $2.20
- PEBK $26.60
- Analyst Decision
- IKT Buy
- PEBK
- Analyst Count
- IKT 2
- PEBK 0
- Target Price
- IKT $8.00
- PEBK N/A
- AVG Volume (30 Days)
- IKT 167.2K
- PEBK 7.4K
- Earning Date
- IKT 03-26-2025
- PEBK 04-21-2025
- Dividend Yield
- IKT N/A
- PEBK 3.47%
- EPS Growth
- IKT N/A
- PEBK 7.58
- EPS
- IKT N/A
- PEBK 2.98
- Revenue
- IKT $1.00
- PEBK $82,079,000.00
- Revenue This Year
- IKT N/A
- PEBK N/A
- Revenue Next Year
- IKT N/A
- PEBK N/A
- P/E Ratio
- IKT N/A
- PEBK $8.99
- Revenue Growth
- IKT N/A
- PEBK 7.90
- 52 Week Low
- IKT $1.12
- PEBK $23.74
- 52 Week High
- IKT $4.20
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- IKT 45.02
- PEBK 37.85
- Support Level
- IKT $1.91
- PEBK $26.40
- Resistance Level
- IKT $2.22
- PEBK $27.29
- Average True Range (ATR)
- IKT 0.25
- PEBK 0.60
- MACD
- IKT -0.01
- PEBK 0.04
- Stochastic Oscillator
- IKT 29.59
- PEBK 57.59
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.